ANNUAL REPORT 2011 - Epilepsy Australia
ANNUAL REPORT 2011 - Epilepsy Australia
ANNUAL REPORT 2011 - Epilepsy Australia
- No tags were found...
Transform your PDFs into Flipbooks and boost your revenue!
Leverage SEO-optimized Flipbooks, powerful backlinks, and multimedia content to professionally showcase your products and significantly increase your reach.
<strong>Epilepsy</strong><strong>Epilepsy</strong> is a disorder of brain function that takesthe form of recurrent convulsive or non-convulsiveseizures.<strong>Epilepsy</strong> is the most common serious braindisorder and today affects some 230,000<strong>Australia</strong>ns and 50 million people globally.<strong>Epilepsy</strong> can be treated and the majority ofpeople diagnosed with epilepsy will gain control oftheir seizures by taking prescribed medications.However for some, achieving seizure control willbe a long, difficult and frustrating time while otherswill experience seizures that do not respond tomedication at all.For many years epilepsy has been misunderstoodand misrepresented within the community, oftenlimiting the person with epilepsy from participatingfully in society. Living with epilepsy is hard enoughwithout the added burden of social stigma fuelledby ancient fears.Attitudes must be based on fact not fiction and itis the commitment of <strong>Epilepsy</strong> <strong>Australia</strong> to changecommunity attitudes through education and publicawareness campaigns.EPILEPSY AUSTRALIA<strong>Epilepsy</strong> ACT<strong>Epilepsy</strong> Queensland<strong>Epilepsy</strong> Tasmania<strong>Epilepsy</strong> Association of Western <strong>Australia</strong><strong>Epilepsy</strong> Foundation of VictoriaThe <strong>Epilepsy</strong> Centre, South <strong>Australia</strong> & Northern Territory<strong>Epilepsy</strong> <strong>Australia</strong> is an Associate Member of the International Bureau for <strong>Epilepsy</strong>2
ContentsPresident’s Report 4Executive Officer’s Review 5Financial Report 7Directors’ Report 8Auditor’s Independence Declaration 9Statement of Comprehensive Income 10Statement of Financial Position 11Statement of Changes in Equity 12Statement of Cash Flows 13Notes to the Financial Statements 14Directors’ Declaration 18Independent Auditor’s Review Report 193
Dr Christine WalkerPresident’s ReportOnce again this year we wereable to review our strategicplan and work towards well-definedaims. These include more fundraisingactivities, the adoption of trainingprograms nationally, and research todevelop an evidence-base with whichto argue for better services for peoplewith epilepsy.Highlights of the year include:The Asian and Oceanian <strong>Epilepsy</strong>Congress which was held inMelbourne. This congress attracteda large number of delegates fromacross the region as well as manystaff of the <strong>Australia</strong>n <strong>Epilepsy</strong>Associations. Thanks to theorganisational skills of our EO the<strong>Epilepsy</strong> & Society Symposium wasa great success. An educationalgrant from Janssen-Cilag enabledmany people with epilepsy to attend.We greatly appreciated their support.Two valuable presentations stoodout. One related to SUDEP wherefamilies of people with epilepsy wereable to hear from Jennifer Preston,<strong>Epilepsy</strong> Bereaved UK, and RoseyPanelli, who is currently coordinatingthe Reducing <strong>Epilepsy</strong> Death projectin <strong>Australia</strong>. Many families wereable to share their experiences andgain from one another. The other,looked at sexuality and epilepsy.Presenters discussed the difficultiesof pregnancy for women on AEDS,Polycystic Ovarian Syndrome(PCOS) and bone health.The <strong>Australia</strong>n <strong>Epilepsy</strong> ResearchRegister continues to recruit fromaround <strong>Australia</strong>. It is our intentionto make this the basis for nationallongitudinal research to develop anevidence base with which to arguefor better services of all peoplein <strong>Australia</strong> who have epilepsythemselves or care for someone withit. All our members are now activelyrecruiting people to this researchdatabase.<strong>Epilepsy</strong> <strong>Australia</strong> saw some newpeople arrive to contribute theirexpertise and effectively representtheir state organisations. Wewelcomed Mr Suresh Rajan of the<strong>Epilepsy</strong> Association of Western<strong>Australia</strong> and we welcomed back Dr4Lindsay Vowels, <strong>Epilepsy</strong> FoundationVictoria. Ms Reachelle Beasley,<strong>Epilepsy</strong> Tasmania, was only withus for a short time due to her recentmove to Singapore. Howeverduring her time on the Board of<strong>Epilepsy</strong> <strong>Australia</strong> she made a greatcontribution and will be missed. MrTony Chapman has recently beenappointed CEO <strong>Epilepsy</strong> Tasmaniaand we look forward to working withhim.It is with regret that we acknowledgethe passing of Ms Ira Effrett whoworked for many years with <strong>Epilepsy</strong>Foundation Victoria. She was apassionate worker with people withepilepsy in regional Victoria. We sendour regards to her family and knowhow sorely she will be missed.Finally we must acknowledge thecontributions of our members andteam. Denise Chapman continues toundertake the work of several peopleas Executive Officer of <strong>Epilepsy</strong><strong>Australia</strong> and JECA. The continuedhigh quality of The <strong>Epilepsy</strong> Reportand her presence in our regionon the International Bureau for<strong>Epilepsy</strong> (IBE) Regional Executiveare testimony to the value she addsto <strong>Epilepsy</strong> <strong>Australia</strong>. Ms JacintaCummins has played an importantpart for <strong>Epilepsy</strong> <strong>Australia</strong> and JECAin working with the ParliamentaryFriends of <strong>Epilepsy</strong> and as VicePresident of <strong>Epilepsy</strong> <strong>Australia</strong>. MrRobert Cole has served us well asTreasurer and also brings us creditthrough his work with the IBE.Dr Christine WalkerPresident<strong>Epilepsy</strong> <strong>Australia</strong>
Denise ChapmanWho will forget the summer of2010-<strong>2011</strong>. From bushfiresto floods in WA, the devastation ofcyclone Yasi in North Queenslandand the heartbreaking floods thatinundated south Queensland,Northern NSW and one-third ofthe state of Victoria. Only to bequickly followed by the horror of theChristchurch earthquake that shookour Kiwi neighbours to their core.And we did what Aussies do: weopened our hearts and emptiedour pockets to help those here andacross the Tasman put their livesback together.Understandably, those in such needbecame a priority and at <strong>Epilepsy</strong><strong>Australia</strong> we held back with our owndonation campaigns in the interim.And yet for a such difficult year Iam able to report a modest profit of$1,644 was achieved.Since inception <strong>Epilepsy</strong> <strong>Australia</strong>’sfinancial year ended 31 August.This year the reporting period waschanged to 30 June to coincide withour member bodies. Consequentlythe financial data for the current yearrelates to the 10 month period ended30 June <strong>2011</strong>, while the comparativedata is for the 12 month period ended31 August 2010.Commitment to ConsumerAdvocacy<strong>Epilepsy</strong> <strong>Australia</strong> continues tobe a national voice for peoplewith epilepsy. We were invited toparticipate in a Government reviewof the disability impairment tablesfollowing our initial submission andExecutive Officer’s Reviewwe were able to provide constructivefeedback. The new tables will takeeffect from 1 January 2012 andwill be monitored over the next 18months.In June we joined with 60 of<strong>Australia</strong>’s biggest health consumerorganisations in a campaign tocondemn the Federal Governmentfor its short sighted cost savingpolicy to shelve critical medicines forthe chronically ill. This was of greatconcern for us, as new AEDs arequite costly and while the decision inFebruary to defer PBS listings did notinclude a new epilepsy medicationthis time, if this policy remained inplace, access to new AEDs in thefuture could be greatly diminished.This campaign, led by theConsumers’ Health Forum, has beensuccessful with the Governmentannouncing on 30 September anagreement had been reached ondeferrals for 12 months from 1October <strong>2011</strong> and that all medicinesand price increases deferredfrom February <strong>2011</strong> are to belisted immediately on the PBS (1December <strong>2011</strong>). As part of thisagreement, consumers will havea seat at the table in discussionsaround budget measures and futurePBS policy.<strong>Epilepsy</strong> <strong>Australia</strong> also providedconsumer representation at aworkshop on the use of technologyin the healthcare sector, and how thistechnology will help individuals livingwith chronic illness, their carers andhealthcare workers.Recognised as the peak epilepsybody, <strong>Epilepsy</strong> <strong>Australia</strong> continuesto represent nationally the interestsof the State <strong>Epilepsy</strong> Associationsand all people living with epilepsy.<strong>Epilepsy</strong> <strong>Australia</strong> membership ofbodies such as the National DisabilityService, Consumers’ Health Forumand the Chronic Illness Alliance, andrepresentation at industry bodiessuch as Medicines <strong>Australia</strong> and thePharmacy Guild, provides ongoingopportunities at a national level toadvocate on behalf of people withepilepsy.5National <strong>Epilepsy</strong> AwarenessCampaign & Purple Day 26MarchThe National <strong>Epilepsy</strong> AwarenessCampaign ran during the month ofMarch with televised communityservice announcements featuring(CSAs) Wally Lewis and PurpleDay founder Cassidy Megan shownacross the country.Purple Day for <strong>Epilepsy</strong>, March 26,is a grassroots effort dedicated toincreasing awareness about epilepsyworldwide initiated in 2008 by youngCassidy Megan from Nova Scotia.Since then, the concept of PurpleDay has captured the imaginationof people living with epilepsy andepilepsy support organizationsaround the world.<strong>Epilepsy</strong> <strong>Australia</strong> is <strong>Australia</strong>’sofficial Purple Day Partner and,through its members and supporters,held Purple Day Events across thecountry.The challenge to ‘go purple forepilepsy’ was taken up with greatenthusiasm by corporations, sportingbodies, school, retail outlets, and thecommunity in general, all eager toparticipate in raising awareness ofepilepsy.Thousands of students learned moreabout epilepsy and what to do ifthey saw someone having a seizure,while participating in fun Purple Dayactivities.Our Purple Day Heroes spread theword among colleagues and friendsselling <strong>Epilepsy</strong> <strong>Australia</strong>’s PurpleDay products, raising valuablefunds to help us continue our workproviding services to all <strong>Australia</strong>nsliving with epilepsy.Overall the ‘Purple Day Hero’campaign was extremely successfuland preparation for 2012 NationalAwareness Campaign is wellunderway.Research, Education &Training our PriorityThis year saw the <strong>Epilepsy</strong>Foundation of Victoria ResearchParticipants Register go nationalunder the banner of <strong>Epilepsy</strong>
<strong>Australia</strong>. Now named the <strong>Australia</strong>n<strong>Epilepsy</strong> Research Register, weencourage all people with epilepsy toregister and become part of a uniquedatabase that has the potential tochange community attitudes andgovernment policies around epilepsy.<strong>Epilepsy</strong> <strong>Australia</strong>’s SUDEPResearch & Education Fund, throughgenerous donations received frombereaved families, and those wishingto support epilepsy research,continues to grow enabling us tosupport two projects this year:■ Reducing <strong>Epilepsy</strong> Death (RED)Project, coordinated by Dr RoseyPanelli, (for more information visit ourwebsite), and our latest publication■ SUDEP: continuing the globalconversation.For this 2nd edition, Jane Hanna(<strong>Epilepsy</strong> Bereaved UK) and TamzinJeffs (SUDEP Aware Canada)joined <strong>Epilepsy</strong> <strong>Australia</strong>’s editorialteam of Chapman and Panelli. Thispartnership, combined with a list ofcontributing authors that’s reads as awho’s who of the epilepsy world andthe endorsement of the IBE, confirmsthe high regard our editors are heldinternationally.Launched at the recent 29thInternational <strong>Epilepsy</strong> Congress,Rome, 10,000 copies of the bookhave been distributed throughoutthe UK and Ireland, Europe, NorthAmerica, New Zealand and <strong>Australia</strong>.Published in the interest ofcommunity awareness andunderstanding, copies of the bookfor <strong>Australia</strong>n distribution wereprinted with support from the SUDEPResearch & Education Fund.The book is available online at www.sudepglobalconversation.com or,if preferred, a hard copy can beobtained by contacting <strong>Epilepsy</strong><strong>Australia</strong> on 1300 852 853.We thank our supporters of the Fund.Without them we would not be ableto undertake such important work.Continuing our commitment forquality consumer education,<strong>Epilepsy</strong> <strong>Australia</strong> developed andorganised the highly successful<strong>Epilepsy</strong> & Society Program, heldin conjunction with the MelbourneCongress. The full day programattracted the greatest number ofparticipants in its 14 year history. Itwas very satisfying to see so manypeople get so much out of the day.<strong>Epilepsy</strong> <strong>Australia</strong> thanks Janssen-Cilag for the educational grant thatallowed people with epilepsy toattend the day through subsidisedregistration fees.Demand for professional epilepsytraining from government bodies,community and disability services,teachers, and nurses continues toincrease throughout the country.<strong>Epilepsy</strong> <strong>Australia</strong>’s members havelong established a reputation fordelivering quality epilepsy trainingacross all sectors and with ongoingdevelopment and assessment oftraining packages, have set thestandard for epilepsy training in<strong>Australia</strong>.Raising awareness of epilepsy inthe workplace continues to be apriority for <strong>Epilepsy</strong> <strong>Australia</strong>. Anew publication <strong>Epilepsy</strong> and theWorkplace: A guide for workersand employers, prepared under thesupervision of member <strong>Epilepsy</strong>ACT for <strong>Epilepsy</strong> <strong>Australia</strong>, includesinformation for workers with epilepsyand employers on their rights andresponsibilities in the workplace.It also explains the legal optionsavailable for people with epilepsywho feel they have been unfairlytreated in employment matters.This document can be downloadedfrom the <strong>Epilepsy</strong> <strong>Australia</strong> website,while hard copies are available from<strong>Epilepsy</strong> ACT.Our work in the regionMelbourne’s hosting of the 8th Asian& Oceanian <strong>Epilepsy</strong> Congress(AOEC) was a great success. JECAwas involved in organising theCongress through Graeme Shears,and both Robert Cole (<strong>Epilepsy</strong>SA & NT) and Denise Chapmanrepresented <strong>Epilepsy</strong> <strong>Australia</strong>on the Scientific ConsultativeCommittee.<strong>Epilepsy</strong> <strong>Australia</strong> hasrepresentation on the IBE WesternPacific Region Executive Committee:Robert Cole, as Chair, and DeniseChapman as Secretary - bothvoluntary roles. It is with greatpleasure to report that Robert hasbeen invited to Co-Chair the 9thAOEC in Manila, Philippines in March2012. We congratulate Robert on thisachievement.6Dr Michelle Bellon and DeniseChapman have been invited toManila to speak at the <strong>Epilepsy</strong> &Society program, while Dr ChristineWalker will be presenting at thescientific program.Outstanding Person with<strong>Epilepsy</strong> AwardDr Michelle Bellon was a most worthyinaugural <strong>Australia</strong>n recipient of theOutstanding Person with <strong>Epilepsy</strong>Award, presented at the MelbourneCongress, in recognition of herongoing commitment to the epilepsycommunity. This award recognisedMichelle’s significant contribution inraising the profile of epilepsy andhelping reduce stigma over manyyears.Ambassador for <strong>Epilepsy</strong>AwardAt the Rome International <strong>Epilepsy</strong>Congress the IBE and the ILAEpresented Dr Rosey Panelli with anAmbassador for <strong>Epilepsy</strong> Award inrecognition of her work developingpeer support workers in epilepsy careteams, her SUDEP work includingepilepsy memorial services, and thepublication of the global conversationbooks (2005, <strong>2011</strong>).We congratulate Rosey in joining avery elite group of six <strong>Australia</strong>nswho have received this awardover the past 50 years: Prof SamBerkovic, Dr Peter Bladin, Dr ErnestSomerville, Mr Robert Gourley, HonMrs Ruby Hutchinson, and Mr FrankBurroughs.I wish to express my appreciationfor the support I have receivedthroughout the year from all membersof <strong>Epilepsy</strong> <strong>Australia</strong>, and in particularour President, Christine Walker, forher guidance and leadership; JacintaCummins for sharing the load whenneeded; and Robert Cole for hishumour and unflagging optimism.I look forward to a productive andexciting year.Denise ChapmanExecutive Officer<strong>Epilepsy</strong> <strong>Australia</strong>
Financial Report forthe year ended30 June <strong>2011</strong><strong>Epilepsy</strong> <strong>Australia</strong> LimitedABN 14 097 003 3827
Directors’ ReportYour directors present their financial report on <strong>Epilepsy</strong> <strong>Australia</strong> Ltd for the period ended 30 June <strong>2011</strong>.The names of the directors throughout the period and at the date of this report unless otherwise stated are:Robert Leslie ColeChristine Florence WalkerJan Margaret TaylorRichard James EcclesMichelle Lisa Bellon Reachelle Peta Beasley (appointed 19/7/2010)Helen Louise Whitehead (appointed 10/2/<strong>2011</strong>) Margo Jacqueline Bastow (appointed 10/2/<strong>2011</strong>)Patricia Jacinta O’Donnell (appointed 7/4/<strong>2011</strong>) Lindsay Margaret Vowels (appointed 7/4/<strong>2011</strong>)The principal activities of the Company during the financial year were:To prepare, publish and distribute handbooks, papers, articles and other educational material, to hold seminars andlectures, and to advocate on behalf of people living with epilepsy, all with the view to fostering national consumer educationsso that consumers may make informed choices and decisions about epilepsy.No significant change in the nature of these activities occurred during the year.The profit from ordinary activities after income tax amounted to $1,644.No matter of circumstances have arisen since the end of the financial year which significantly affected or maysignificantly affect the operations of the company, the results of those operations or the state of affairs of the companyin future financial years.Meeting attendance Attended Board Meetings EligibleRobert Cole 4 4Jan Taylor 4 4Michelle Bellon 4 4Helen Whitehead (appointed 10/2/<strong>2011</strong>) 1 1Patricia O’Donnell 1 1Christine Walker 4 4Richard Eccles 0 4Reachelle Beasley 4 4Margo Bastow 0 1Lindsay Vowells 1 1Auditor’s Independence DeclarationA copy of the auditor’s independence declaration as required under section 307C of the Corporations Act 2001 is setout on page 9.Signed in accordance with a resolution of the Board of Directors:The accompanying notes form part of this financial report.8
Statement of comprehensive incomefor the period ended 30 June <strong>2011</strong>10 months 12 monthsendedendedRevenueNote 30 June <strong>2011</strong> 31 August 2010$ $Fundraising - Donations 11,312 14,299Fundraising - Community 57,312 28,791Bequests - 18,198States Contributions 43,700 93,829Sundry Income 13,886 14,222Training Income 4,030 3,931130,240 173,270ExpensesAdministration 3,784 8,687Accounting and Audit Expense 3,833 1,500Advertising and Promotion 8,183 12,505Computer Expense 4,794 13,258Conference and Travel Expense 12,533 7,899Depreciation Expense - 78Fundraising Expense 19,179 9,850Loss on Disposal of Asset 2,148 -Personnel Expense 61,086 59,658Printing and Publication Expense 14,242 8,617SUDEP Expense 1,878 -Sundry Expense 1,609 15,902Telecommunication Expense 5,619 8,179128,596 139,863Profit before income tax 1,644 33,407Income Tax Expense 2 - -Profit after income tax 1,644 33,407Total other comprehensive income - -Total comprehensive income for the year 1,644 33,407The accompanying notes form part of this financial report.10
Statement of financial positionfor the period ended 30 June <strong>2011</strong>CURRENT ASSETSNote 30 June <strong>2011</strong> 31 August 2010$ $Cash and cash equivalents 3 72,678 65,674Trade and other receivables 4 31,521 22,345TOTAL CURRENT ASSETS 104,199 88,019NON-CURRENT ASSETSProperty, plant & equipment 5 - 2,146TOTAL NON-CURRENT ASSETS - 2,146TOTAL ASSETS 104,199 90,165CURRENT LIABILITIESTrade and other payables 6 19,784 12,028Provisions 7 12,533 7,899TOTAL CURRENT LIABILITIES 32,317 19,927TOTAL LIABILITIES 32,317 19,927NET ASSETS 71,882 70,238MEMBERS’ FUNDSRetained profits 71,882 70,238TOTAL MEMBERS’ FUNDS 71,882 70,238The accompanying notes form part of this financial report.11
Statement of changes in equityfor the period ended 30 June <strong>2011</strong>Retained TotalEarnings$ $Balance at 1st September 2009 36,831 36,831Profit attributable to the entity 33,407 33,407Balance at 31st August 2010 70,238 70,238Profit attributable to the entity 1,644 1,644Balance at 30th June <strong>2011</strong> 71,882 71,882The accompanying notes form part of this financial report.12
Statement of cash flowsfor the period ended 30 June <strong>2011</strong>CASH FLOWS FROM OPERATING ACTIVITIESNote 30 June <strong>2011</strong> 31 August 2010$ $Receipts from customers & other sources 130,079 153,368Payments to suppliers and employees (123,236) (119,547)Interest received 161 128Net Cash provided by operatingactivities 8 7,004 33,947CASH FLOWS FROM FINANCING ACTIVITIESRepayment of loans - -Net Cash provided by (used in) financingactivities - -CASH FLOWS FROM INVESTING ACTIVITIESPayments for purchase of propertyand equipment - -Net Cash provided by (used in ) investingactivities - -Net increase (decrease) in cash held 7,004 33,947Cash at the beginning of the year 65,674 31,727Cash at the end of the year 72,678 65,674The accompanying notes form part of this financial report.13
Notes to the financial statementsfor the period ended 30 June <strong>2011</strong>Note 1: Statement of Significant Accounting PoliciesThe directors have prepared the financial statements on the basis that the company is a non-reporting entitybecause there are no users who are dependent on its general purpose financial reports. These financial statementare therefore special purpose financial statements that have been prepared in order to meet the requirements of theCorporations Act 2001.The financial statements have been prepared in accordance with the mandatory <strong>Australia</strong>n Accounting Standardsapplicable to entities reporting under the Corporations Act 2001 and the significant accounting policies disclosedbelow, which the directors have determined are appropriate to meet the needs of members. Such accounting policiesare consistent with the previous period unless stated otherwise.The financial statements have been prepared on an accruals basis and are based on historical costs unless otherwisestated in the notes. The accounting policies that have been adopted in the preparation of the report are as follows:a. Cash and Cash EquivalentsCash and cash equivalents included cash on hand, deposits held at call with banks, and other short-term highlyinvestment with original maturities of three months or less.b. Income TaxNo provision for income tax has been raised, as the entity is exempt from income tax under Div 50 or the IncomeTax Assessment Act 1997.c. Property, Plant and EquipmentEach class of property, plant and equipment is carried at cost or fair values as indicated, less, where applicable,accumulated depreciation and impairment losses.Leasehold improvements and office equipment are carried at cost less, where applicable, any accumulateddepreciation.The depreciable mount of property, plant and equipment is depreciated over the useful lives of the assets to thecompany commencing from the time the asset is held ready for use. Leasehold improvements are amortised overthe shorter of either the unexpired period of the lease or the estimated useful lives of the improvements.d. Employee EntitlementsProvision is made for the entity’s liability for employee benefits arising from services rendered by employees tothe end of the reporting period. Employee benefits that are expected to be settled within one year havebeen measured at the amount expected to be paid when the liability is settled. Employee benefits payable laterthan one year have been measured at the present value of the estimated future cash outflows to be made forthose benefits.Provision is made for the entity’s liability for long service leave from commencement of employment not from the 5year employment period normally accrued as industry practice.e. ProvisionsProvisions are recognised then the entity has a legal or constructive obligation, as a result of past events, forwhich it is probable that an outflow of economic benefits will result and that outflow can be reliably measured.f. Impairment of AssetsAt the end of each reporting period, the entity reviews the carrying values of its tangible and intangible assetsto determine whether there is an indication that those assets have been impaired. If such an indication exists,the recoverable amount of the asset, being the higher of the asset’s fair value less costs to sell and value in use,is compared to the asset’s carrying value. Any excess of the asset’s carrying value over its recoverable amount isexpenses to the income statement.g. RevenueRevenue is brought to account when received and to the extent that it relates to the subsequent period it isdisclosed as a liability.Grant IncomeGrant income received, other than for specific purposes, is brought to account for the period to which the grantrelates.14
Notes to the financial statementsfor the period ended 30 June <strong>2011</strong>Deferred IncomeUnspent grant income received in relation to specific projects and events is not brought to account as revenue inthe current year but deferred as a liability in the financial statements until spent for the purpose received.Capital GrantsGrant income received relating to the purchase of capital items is shown as Unamortised Capital Grant andbrought to account over the expected life of the asset in proportion to the related depreciation charge.Interest RevenueInterest revenue is recognised using the effective interest rate method, which for floating rate financial assets isthe rate inherent in the instrument.DonationsDonations income is recognised when the entity obtains control over the funds which is generally at the time ofreceipt.h. Goods and Services Tax (GST)Revenues, expenses and assets are recognised net of the amount of GST, except where the amount of GSTincurred us not recoverable from the Tax Office. In these circumstances, the GST is recognised as part of the costof acquisition of the asset or as part of an item of the expense. Receivables and payable in the assets andliabilities statement are shown inclusive of GST.i Adoption of New and Revised Accounting StandardsDuring the current the company adopted all of the new and revised <strong>Australia</strong>n Accounting Standards andInterpretations applicable to its operations which became mandatory. The adoption of these standards hasimpacted the recognition, measurement and disclosure of certain transactions. The following is an explanation ofthe impact the adoption of these standards and interpretations has had on the financial statements of the entity.In September 2007 the <strong>Australia</strong>n Accounting Standards Board revised AASB 101 and as a result, there havebeen changes to the presentation and disclosure of certain information within the financial statements. Below is anoverview of the key changes and the impact on the company’s financial statements.Disclosure impactTerminology changes — The revised version of AASB 101 contains a number of terminology changes includingthe amendments of the names of the primary financial statements.Reporting changes in equity — The revised AASB 101 requires all changes in equity arising from thetransactions with owners, in their capacity as owners, to be presented separately from the non-owner changes inequity. Owner changes in equity are to be presented in the statement of changes in equity, with non-ownerchanges in equity presented in the statement of comprehensive income. The previous version of AASB 101required that owner changes in equity and other comprehensive income be presented in the statement of changesin equity.Statement of comprehensive income — The revised AASB 101 requires all income and expenses to bepresented in either one statement, the statement of comprehensive income, or two statements, a separateincome statement and a statement of comprehensive income. The previous version of AASB 101required only the presentation of a single income statement. The entity has elected to present one statement.Other comprehensive income — The revise version of AASB 101 introduces the concept of ‘othercomprehensive income’ which comprises of income and expenses that are not recognised in profit or loss asrequired by other <strong>Australia</strong>n Accounting Standards. Items of other comprehensive income are to be disclosed inthe statement of comprehensive income. Entities are required to disclose the income tax relating to eachcomponent of the other comprehensive income. The previous version of AASB 101 did not contain an equivalentconcept. Of the issued, not yet adopted standards, preliminary reviews indicate there will be no material impactsfrom their adoption.15
Notes to the financial statementsfor the period ended 30 June <strong>2011</strong>30 June <strong>2011</strong> 31 August 2010$ $Note 8: Reconciliation of Cash Flow fromOperations with Profit from OrdinaryActivities after Income TaxProfit after income tax 1,644 33,407Cash flows excluded from operating profit attributableto operating activities;- Depreciation - 78- Loss on disposal 2,146 -Changes in assets and liabilities;- (Increase)/decrease in trade and other debtors (9,178) (19,778)- Increase /(decrease) in trade and other payables 7,756 12,339- Increase /(decrease) in provisions 4,634 7,899Net cash provided by Operating Activities 7,004 33,947Note 9: Company DetailsThe registered office of the company is:<strong>Epilepsy</strong> <strong>Australia</strong> Ltd818 Burke RoadCamberwell VIC 3124Note 10: Comparative FiguresThe company has chosen to change its financial year end from 31 August to 30 June, to coincide with the financialyear of its member bodies. Consequently, financial data for the current years relates to the 10 month period ended30 June <strong>2011</strong>, while the comparative data is for the 12 month period ended 31 August 2010.Where required by Accounting Standards, comparative figures have been adjusted to conform with changes in presentationfor the current financial year.When the company applies an accounting policy retrospectively, makes a retrospective restatement or reclassifiesitems in its financial statements, a statement of financial position as at the beginning of the earliest comparativeperiod must be disclosed.Note 11: Members GuaranteeThe entity is incorporated under the Corporations Act 2001 and is an entity limited by guarantee. If the entity iswound up, the constitution states that each member is required to contribute a maximum of $10 each towards meetingany outstandings and obligations of the entity. At 30 June <strong>2011</strong> the number of members was 6.17
Directors’ DeclarationThe directors have determined that the Company is not a reporting entity and that this special purpose financialreport should be prepared in accordance with the accounting policies in Note 1 to the financial statements.The directors of the Company declare that:1. The financial statements and notes, as set out on pages 9 to 20 are in accordance with the Corporations Act2001; and(a)(b)comply with Accounting Standards as described in Note 1 to the financial statements a and theCorporations Regulations 2001; andgive a true and fair view of the company’s financial position as at 30 June <strong>2011</strong> and its performancefor the year then ended on that date in accordance with accounting policies described in Note 1 to thefinancial statements.2. In the directors’ opinion there are reasonable grounds to believe that the company will be able to pay its debts asand when they become due and payable.This declaration is made in accordance with a resolution of the Board of Directors.18
PO Box 1049Baulkham Hills NSW 17551300 852 853www.epilepsyaustralia.netepilepsy@epilepsyaustralia.net